<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2018-14-1-53-57</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-1618</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>THE INCIDENCE OF THE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING</article-title><trans-title-group xml:lang="ru"><trans-title>ЧАСТОТА ВОЗНИКНОВЕНИЯ ИШЕМИЧЕСКИХ МИКРООЧАГОВ В ВЕЩЕСТВЕ ГОЛОВНОГО МОЗГА ПРИ СТЕНТИРОВАНИИ СОННЫХ АРТЕРИЙ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булгакова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulgakova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Булгакова Елена Сергеевна –младший научный сотрудник, отдел фундаментальных и прикладных аспектов ожирения </p><p>101990, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"><p>Elena S. Bulgakova – MD, Junior Researcher, Department of Fundamental and Applied Aspects of Obesity </p><p>Petroverigsky per. 10, Moscow, 101990</p></bio><email xlink:type="simple">ebulgakova@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шукуров</surname><given-names>Ф. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Shukurov</surname><given-names>F. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Фирдавс Баходурович – врач-эндоваскулярный хирург отделения рентгенэндоваскулярных методов диагностики и лечения </p><p>101990, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"><p>Firdavs B. Shukurov – MD, Endovascular Surgeon, Department of Roentgen-Endovascular Diagnostics and Treatment (Interventional Cardiology)</p><p>Petroverigsky per. 10, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Руденко</surname><given-names>Б. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rudenko</surname><given-names>B. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Руденко Борис Александрович – доктор медицинских наук, ведущий научный сотрудник лаборатории рентгенэндоваскулярных методов диагностики и лечения </p><p>101990, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"><p>Boris A. Rudenko – MD, PhD, Leading Researcher, Laboratory of Roentgen-Endovascular Diagnostics and Treatment (Interventional Cardiology)</p><p>Petroverigsky per. 10, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Творогова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tvorogova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Творогова Татьяна Васильевна – кандидат медицинских наук, главный врач клиники </p><p>141730, Московская обл., Лобня, ул. Текстильная, 16</p></bio><bio xml:lang="en"><p>Tatiana V. Tvorogova – MD, PhD, Chief Physician </p><p>Textilnaya ul. 16, Moscow Region, Lobnya, 141730</p><p> </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Оксана Михайловна – доктор медицинских наук, профессор, член-корреспондент РАН, директор </p><p>101990, Москва, Петроверигский пер., 10 </p></bio><bio xml:lang="en"><p>Oxana M. Drapkina – MD, PhD, Professor, Corresponding Member of the Russian Academy of Sciences, Director </p><p>Petroverigsky per. 10, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр профилактической медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National MedicalResearch Center for Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Клиника «Семья»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Private Clinic "Family"</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>05</day><month>03</month><year>2018</year></pub-date><volume>14</volume><issue>1</issue><fpage>53</fpage><lpage>57</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Bulgakova E.A., Shukurov F.B., Rudenko B.A., Tvorogova T.V., Drapkina O.M., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Булгакова Е.С., Шукуров Ф.Б., Руденко Б.А., Творогова Т.В., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Bulgakova E.A., Shukurov F.B., Rudenko B.A., Tvorogova T.V., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/1618">https://www.rpcardio.online/jour/article/view/1618</self-uri><abstract><sec><title>Aim</title><p>Aim. To estimate incidence of periprocedural ischemic brain microlesions after carotid artery stenting (CAS) and to identify most probable predictors. Material and methods. 84 patients with carotid artery stenosis undergoing carotid angioplasty with stenting (CAS) in a specialized medical center, between 2013 and 2016, were examined. All patients had diffusion-weighted magnetic resonance imaging before and after treatment for the detection of new periprocedural ischemic brain microlesions. Statistical analysis was performed using non-parametric methods.</p></sec><sec><title>Results</title><p>Results. Among the selected patients aged 40 to 83 years (mean age of 60.6±3.9 years) there were 68 men (80.95%) and 16 women (19.05%). 39 (46.4%) of 84 patients had new ischemic brain microlesions after CAS both ipsilateral (37.8%) and non-ipsilateral location. 17.95% of them (n=7) had the transient or persistent neurological symptoms and the rest patients were asymptomatic. Patients with ischemic brain microlesions compared with patients without them were older and had lower hemoglobin level before CAS, history of previous strokes and as well as perioperative arterial hypotension persisting up to 24 hours (p&lt;0.05). Statistically significant differences in atherosclerotic plaques characteristics and CAS technical features were not detected.</p></sec><sec><title>Conclusion</title><p>Conclusion. Ischemic brain microlesions after CAS, mostly asymptomatic, were detected in about half of patients. Microlesion appearance may be associated with older age, preprocedural lower hemoglobin level, previous strokes and periprocedural hemodynamic instability.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель</title><p>Цель. Оценить частоту возникновения периоперационных церебральных ишемических микроочагов после стентирования сонной артерии и выявить вероятные кардиоваскулярные факторы риска развития этих микроочагов.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследованы 84 пациента со стенозом сонной артерии, подвергшихся каротидной ангиопластике со стентировани- ем (КАС) в специализированном медицинском центре в период с 2013 по2016 г. Для выявления новых периоперационных ишемических микроочагов всем пациентам проводилась магнитно-резонансная томография в режиме диффузионно-взвешенных изображений до и после вмешательства.</p></sec><sec><title>Результаты</title><p>Результаты. Среди отобранных пациентов в возрасте от 40 до 83 лет (средний возраст 60,6Ѓ}3,9 лет) было 68 мужчин (80,95%) и 16 жен- щин (19,05%). У 39 пациентов (46,4%) из 84 после КАС выявлены ишемические микроочаги как ипсилатеральной (37,8%), так и не ип- силатеральной локализации. Из них 17,95% (n=7) сопровождались транзиторной или стойкой неврологической симптоматикой, а осталь- ные были асимптомными. Пациенты с ишемическими микроочагами по сравнению с пациентами без очагов имели более пожилой возраст, более низкий уровень гемоглобина до КАС, наличие ранее перенесенных инсультов и стойкую периоперационную артериальную гипотонию, сохранявшуюся до 24 ч (p&lt;0,05). Статистически значимых различий по характеристикам стентируемой атеросклеротической бляшки и тех- ническими особенностями КАС выявлено не было.</p></sec><sec><title>Заключение</title><p>Заключение. Ишемические микроочаги после КАС, чаще бессимптомные, регистрировались почти в половине случаев. Возникновение мик- роочагов может быть ассоциировано с пожилым возрастом, низким уровнем гемоглобина, ранее перенесенными инсультами, а также не- стабильностью периоперационной гемодинамики.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>атеросклероз сонных артерий</kwd><kwd>ангиопластика со стентированием сонных артерий</kwd><kwd>осложнения</kwd><kwd>церебральная микроэмболия</kwd><kwd>ишемические микроочаги вещества головного мозга</kwd><kwd>магнитно-резонансная томография в режиме диффузионно-взвешенных изображений</kwd></kwd-group><kwd-group xml:lang="en"><kwd>carotid artery disease</kwd><kwd>carotid angioplasty with stenting</kwd><kwd>complications</kwd><kwd>cerebral microemboli</kwd><kwd>ischemic brain microlesions</kwd><kwd>magnetic resonance tomography in the mode of diffusion-weighted images</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Stahovskaya L.V., Kotov S.V. Stroke: a guide for physicians. Moscow: Medicinskoe informacionnoe agentstvo; 2014. (In Russ.) [Стаховская Л.В., Котов С.В. Инсульт: руководство для врачей. М.: Медицинское информационное агентство; 2014].</mixed-citation><mixed-citation xml:lang="en">Stahovskaya L.V., Kotov S.V. Stroke: a guide for physicians. Moscow: Medicinskoe informacionnoe agentstvo; 2014. (In Russ.) [Стаховская Л.В., Котов С.В. Инсульт: руководство для врачей. М.: Медицинское информационное агентство; 2014].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">White C.J. Carotid artery stenting. J Am Coll Cardiol. 2014;64(7):722-31. doi: 10.1016/j.jacc.2014.04.069.</mixed-citation><mixed-citation xml:lang="en">White C.J. Carotid artery stenting. J Am Coll Cardiol. 2014;64(7):722-31. doi: 10.1016/j.jacc.2014.04.069.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">O'Brien M., Chandra A. Carotid revascularization: risks and benefits. Vasc Health Risk Manag. 2014;10:403-16. doi: 10.2147/VHRM.S48923.</mixed-citation><mixed-citation xml:lang="en">O'Brien M., Chandra A. Carotid revascularization: risks and benefits. Vasc Health Risk Manag. 2014;10:403-16. doi: 10.2147/VHRM.S48923.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kernan W.N., Ovbiagele B., Black H.R. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2014;45(7):2160-236. doi: 10.1161/STR.0000000000000024.</mixed-citation><mixed-citation xml:lang="en">Kernan W.N., Ovbiagele B., Black H.R. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2014;45(7):2160-236. doi: 10.1161/STR.0000000000000024.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gahremanpour A., Perin E.C., Silva G. Carotid artery stenting versus endarterectomy: a systematic review. Tex Heart Inst J. 2012;39(4):474-87.</mixed-citation><mixed-citation xml:lang="en">Gahremanpour A., Perin E.C., Silva G. Carotid artery stenting versus endarterectomy: a systematic review. Tex Heart Inst J. 2012;39(4):474-87.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Patel R.A. State of the art in carotid artery stenting: trial data, technical aspects, and limitations. J Cardiovasc Transl Res. 2014;7(4):446-57. doi: 10.1007/s12265-014-9567-3.</mixed-citation><mixed-citation xml:lang="en">Patel R.A. State of the art in carotid artery stenting: trial data, technical aspects, and limitations. J Cardiovasc Transl Res. 2014;7(4):446-57. doi: 10.1007/s12265-014-9567-3.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tendera M., Aboyans V., Bartelink M.L. et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011;32(22):2851-906. doi: 10.1093/eurheartj/ehr211.</mixed-citation><mixed-citation xml:lang="en">Tendera M., Aboyans V., Bartelink M.L. et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011;32(22):2851-906. doi: 10.1093/eurheartj/ehr211.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenkranz M., Gerloff C. New ischemic brain lesions after carotid artery stenting. J Cardiovasc Surg (Torino). 2013;54(1):93-9.</mixed-citation><mixed-citation xml:lang="en">Rosenkranz M., Gerloff C. New ischemic brain lesions after carotid artery stenting. J Cardiovasc Surg (Torino). 2013;54(1):93-9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Knur R. Technique and clinical evidence of neuroprotection in carotid artery stenting. Vasa. 2014;43(2):100-12. doi: 10.1024/0301-1526/a000336.</mixed-citation><mixed-citation xml:lang="en">Knur R. Technique and clinical evidence of neuroprotection in carotid artery stenting. Vasa. 2014;43(2):100-12. doi: 10.1024/0301-1526/a000336.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hauth E.A., Jansen C., Drescher R. MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting. Am J Neuroradiol. 2005;26:2336-41.</mixed-citation><mixed-citation xml:lang="en">Hauth E.A., Jansen C., Drescher R. MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting. Am J Neuroradiol. 2005;26:2336-41.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Palombo G., Faraglia V., Stella N. et al. Late evaluation of silent cerebral ischemia detected by diffusionweighted MR imaging after filter-protected carotid artery stenting. Am J Neuroradiol. 2008;29:1340-3. doi: 10.3174/ajnr.A1102.</mixed-citation><mixed-citation xml:lang="en">Palombo G., Faraglia V., Stella N. et al. Late evaluation of silent cerebral ischemia detected by diffusionweighted MR imaging after filter-protected carotid artery stenting. Am J Neuroradiol. 2008;29:1340-3. doi: 10.3174/ajnr.A1102.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou W., Dinishak D., Lane B. et al. Long-term radiographic outcomes of microemboli following carotid interventions. J Vasc Surg. 2009;50:1314-9. doi: 10.1016/j.jvs.2009.07.105.</mixed-citation><mixed-citation xml:lang="en">Zhou W., Dinishak D., Lane B. et al. Long-term radiographic outcomes of microemboli following carotid interventions. J Vasc Surg. 2009;50:1314-9. doi: 10.1016/j.jvs.2009.07.105.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wolf P.A., D'Agostino R.B., Kannel W.B. et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988;259(7):1025-9. doi:10.1001/jama.1988.03720070025028.</mixed-citation><mixed-citation xml:lang="en">Wolf P.A., D'Agostino R.B., Kannel W.B. et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988;259(7):1025-9. doi:10.1001/jama.1988.03720070025028.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kawachi I., Colditz G.A., Stampfer M.J. et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269(2):232-6. doi:10.1001/jama.1993.03500020066033.</mixed-citation><mixed-citation xml:lang="en">Kawachi I., Colditz G.A., Stampfer M.J. et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269(2):232-6. doi:10.1001/jama.1993.03500020066033.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bonati L.H., Jongen L.M., Haller S. et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 2010;9:353-62. doi: 10.1016/S1474-4422(10)70057-0.</mixed-citation><mixed-citation xml:lang="en">Bonati L.H., Jongen L.M., Haller S. et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 2010;9:353-62. doi: 10.1016/S1474-4422(10)70057-0.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bijuklic K., Wandler A., Varnakov Y. et al. Risk factors for cerebral embolization after carotid artery stenting with embolic protection: a diffusion-weighted magnetic resonance imaging study in 837 consecutive patients. Circ Cardiovasc Interv. 2013;6(3):311-6. doi: 10.1161/CIRCINTERVENTIONS.112.000093.</mixed-citation><mixed-citation xml:lang="en">Bijuklic K., Wandler A., Varnakov Y. et al. Risk factors for cerebral embolization after carotid artery stenting with embolic protection: a diffusion-weighted magnetic resonance imaging study in 837 consecutive patients. Circ Cardiovasc Interv. 2013;6(3):311-6. doi: 10.1161/CIRCINTERVENTIONS.112.000093.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rostamzadeh A., Zumbrunn T., Jongen L.M. et al. Predictors of acute and persisting ischemic brain lesions in patients randomized to carotid stenting or endarterectomy. Stroke. 2014;45(2):591-4. doi: 10.1161/STROKEAHA.113.003605.</mixed-citation><mixed-citation xml:lang="en">Rostamzadeh A., Zumbrunn T., Jongen L.M. et al. Predictors of acute and persisting ischemic brain lesions in patients randomized to carotid stenting or endarterectomy. Stroke. 2014;45(2):591-4. doi: 10.1161/STROKEAHA.113.003605.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Staubach S., Hein-Rothweiler R., Hochadel M. et al. Predictors of minor versus major stroke during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische KrankenhausКrzte (ALKK). Clin Res Cardiol. 2014;103(5):345-51. doi: 10.1007/s00392-013-0657-z.</mixed-citation><mixed-citation xml:lang="en">Staubach S., Hein-Rothweiler R., Hochadel M. et al. Predictors of minor versus major stroke during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische KrankenhausКrzte (ALKK). Clin Res Cardiol. 2014;103(5):345-51. doi: 10.1007/s00392-013-0657-z.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ichinose N., Hama S., Tsuji T. et al. Predicting ischemic stroke after carotid artery stenting based on proximal calcification and the jellyfish sign. J Neurosurg. 2017;7:1-9. doi: 10.3171/2017.1.JNS162379.</mixed-citation><mixed-citation xml:lang="en">Ichinose N., Hama S., Tsuji T. et al. Predicting ischemic stroke after carotid artery stenting based on proximal calcification and the jellyfish sign. J Neurosurg. 2017;7:1-9. doi: 10.3171/2017.1.JNS162379.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou W., Zareie R., Tedesco M. et al. Risk factors predictive of carotid artery stenting-associated subclinical microemboli. Int J Angiol. 2011;20(1):25-32. doi: 10.1055/s-0031-1272546.</mixed-citation><mixed-citation xml:lang="en">Zhou W., Zareie R., Tedesco M. et al. Risk factors predictive of carotid artery stenting-associated subclinical microemboli. Int J Angiol. 2011;20(1):25-32. doi: 10.1055/s-0031-1272546.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gerhardt U., Vorneweg P., Riedasch M. et al. Acute and persistant effects of smoking on the baroreceptor function. J Auton Pharmacol. 1999;19(2):105-8. DOI: 10.1046/j.1365-2680.1999.00123.x</mixed-citation><mixed-citation xml:lang="en">Gerhardt U., Vorneweg P., Riedasch M. et al. Acute and persistant effects of smoking on the baroreceptor function. J Auton Pharmacol. 1999;19(2):105-8. DOI: 10.1046/j.1365-2680.1999.00123.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Arosio E., De Marchi S., Rigoni A. et al. Effects of smoking on cardiopulmonary baroreceptor activation and peripheral vascular resistance. Eur J Clin Invest. 2006;36(5):320-5. doi: 10.1111/j.13652362.2006.01628.x.</mixed-citation><mixed-citation xml:lang="en">Arosio E., De Marchi S., Rigoni A. et al. Effects of smoking on cardiopulmonary baroreceptor activation and peripheral vascular resistance. Eur J Clin Invest. 2006;36(5):320-5. doi: 10.1111/j.13652362.2006.01628.x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
